Results 301 to 310 of about 151,689 (336)
Some of the next articles are maybe not open access.

Pathogenesis of ABO hemolytic disease

American Journal of Obstetrics and Gynecology, 1960
Abstract 1.1. Observations on 51 families in which ABO hemolytic disease occurred are reviewed. In all but one of the families, the mothers were found to be Group O in conformity with previous reports. This is attributed to the ability of Group O mothers to form antibodies of specificity anti-C as well as anti-A and anti-B. 2.2.
A S, WIENER   +3 more
openaire   +2 more sources

Autoimmune Hemolytic Disease

Archives of Internal Medicine, 1961
Introduction The abnormal red cell destruction in autoimmune hemolytic disease (A. I. H. D.) is attributed to the action of autoantibodies. This concept would be more firmly established if a relationship between the severity of the disease and the amount and variety of the antibodies being formed could be clearly demonstrated.
R S, EVANS, M, BINGHAM, P, BOEHNI
openaire   +2 more sources

Hemolytic Anemia in Wilson's Disease

Annals of Internal Medicine, 1970
Abstract Penicillamine therapy was discontinued for a period of 200 days in a patient with Wilson's disease. Copper reaccumulated in the body at the rate of about 0.43 mg/day.
A, Deiss, G R, Lee, G E, Cartwright
openaire   +2 more sources

Autoimmune hemolytic disease during pregnancy

American Journal of Obstetrics and Gynecology, 1981
Abstract Since autoimmune hemolysis is potentially dangerous to both mother and fetus, detection of it should prompt a search for underlying systemic autoimmune disease, neoplasm, or infection. The severity of maternal anemia and the time of appearance of antibodies do not necessarily correlate with neonatal outcome.
D A, Sacks, L D, Platt, C S, Johnson
openaire   +2 more sources

Phototherapy in hemolytic disease.

Pediatrics, 1972
I agree wholeheartedly with Dr. Lanzkowsky that "phototherapy should be used with extreme caution" and that it is the object of "indiscriminate use . . . bringing in its wake a number of potential hazards." However, I disagree that anemia after use in hemolytic disease is the fault of the therapy.
G, Ente, P, Lanzkowsky
openaire   +3 more sources

Serum Haptoglobin in Hemolytic Disease

JAMA: The Journal of the American Medical Association, 1980
To the Editor.— Inadequate construction of study and control groups by Marchand et al (1980;243:1909) inflates the apparent sensitivity and specificity of their serum haptoglobin assay. More important, there is no reason to believe that the test has much practical value.
openaire   +2 more sources

Beta Hemolytic Streptococcal Diseases

Archives of Pediatrics & Adolescent Medicine, 1979
Burtis B. Breese, MD, was a newly licensed physician in 1931. It is astounding to think of the changes in medicine that have taken place since then—changes that medical students and young physicians, understandably, do not think about or cannot fully comprehend—changes that Dr Breese was involved in because of his sustained interest in one important ...
openaire   +1 more source

Hemolytic Disease

Clinical Obstetrics and Gynecology, 1973
openaire   +2 more sources

ABO Hemolytic Disease

Clinical Obstetrics and Gynecology, 1982
openaire   +2 more sources

Hemolytic Disease

Archives of Pediatrics & Adolescent Medicine, 1983
openaire   +1 more source

Home - About - Disclaimer - Privacy